In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
July 4th, 2006 | 40 | No |
Popular Name: Streptomycin Streptomycin
3810-74-0; D01350; Streptomycin sulfate (JP16/USP); Streptomycin sulfate (TN)
57-92-1; D08531; SM; Streptomycin (INN); Streptomycin (TN)
CHEBI:45745; CHEBI:9284; CHEBI:15119; CHEBI:26784
EINECS 228-182-9; LS-147062; Streptomycin hydrochloride; Streptomycin, trihydrochloride
INN); Streptomycin Sulfate (FDA
Streptomycin Sesquisulfate Hydrate
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | -5.28 | -14.78 | -150.46 | 19 | 19 | 3 | 339 | 584.604 | 11 | ↓ |
Mid Mid (pH 6-8) | -5.28 | -16.18 | -95.14 | 18 | 19 | 2 | 335 | 583.596 | 11 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
ALOGPS_SOLUBILITY | 1.28e+01 g/l | DrugBank-approved |
mechanism | Activity increased in alkaline medium binds irreversibly to the bacterial ribosomal 30S subunit | IBScreen Bioactives |
UniProt Database Links | AFRP_STRGR; AFSA_STRGR; APHE_STRGR; GLSA_STRGR; ICAR_STAEQ; MCA_MYCS2; MFS55_MYCBO; NORM_VIBCH; NORM_VIBPA; OBG_STRGR; RMLA_STRGR; RMLB_STRGR; RMLC_STRGR; RMLD_STRGR; RR12_SOLNI; RR5_SPIOL; RS12_BACSU; RS12_BARHE; RS12_ECOLI; RS12_HAEIN; RS12_LEPBP; RS12_ | ChEBI |
biological_use | Aminoglycoside antibiotic | IBScreen Bioactives IBScreen Bioactives |
mechanism | Apoptosis-inducer | IBScreen Bioactives |
mechanism | Blocks the recognition step in protein-synthesis | IBScreen Bioactives |
mechanism | Causes misreading of the genetic code | IBScreen Bioactives |
mechanism | Causes ribosomal dissociation from messenger RNA | IBScreen Bioactives |
biological_use | Clinically used broad spectrum antibacterial (tuberculostatic) agent | IBScreen Bioactives |
PUBCHEM_PATENT_ID | EP0520843A2; EP0520843A3; EP0716690A1; EP1017800A1; EP1020529A3; EP1029062A1; US4777136; US4918163; US5100791; US5482856; US5484591; US5541095; US5629198; US5698198; US5912266; US5932483; US5977076; US6004948; US6146883; WO1993009838A1; WO1995006716A1; WO | IBM Patent Data |
Patent Database Links | EP1452533; EP1522307; EP1588702; EP1598059; EP1607406; EP1700845; EP1803463; EP1815856; EP1908754; EP1956079; EP1972684; GB1585736; GB2103617; US2003105066; US2004198669; US2005065197; US2006222684; US2007185040; US2007202051; US2007202077; US2007207222 | ChEBI |
mechanism | Protein synthesis inhibitor | IBScreen Bioactives IBScreen Bioactives |